KROS
Keros Therapeutics, Inc. · NASDAQ
- Sector Health Technology
- Industry Pharmaceuticals: Major
- Website kerostx.com
- Employees(FY) 129
- ISIN US4923271013
Performance
+0.1%
1W
-6.35%
1M
+12.26%
3M
+85.17%
6M
+47.59%
YTD
+36.15%
1Y
Profile
Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical need in the United States. The company's lead protein therapeutic product candidate KER-050, which is being developed for the treatment of low blood cell counts, or cytopenias, including anemia and thrombocytopenia in patients with myelodysplastic syndromes, as well as in patients with myelofibrosis. It also develops KER-047, a small molecule product candidate that is in Phase II clinical trials for the treatment of functional iron deficiency; and KER-012, which is in Phase II clinical trials to treat pulmonary arterial hypertension and cardiovascular disorders. Keros Therapeutics, Inc. was incorporated in 2015 and is headquartered in Lexington, Massachusetts.
Investment Analysis Report: KROS
Overview
In this investment analysis report, we will delve into the financial statements of KROS, a company operating in the Health Technology sector within the Pharmaceuticals: Major industry. We will analyze the company's financial health, earnings and revenue growth, profitability, operating margin, operating ...
Technical Analysis of KROS 2024-05-03
Overview:
In analyzing the technical indicators for KROS over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement. By examining these key aspects, we aim to offer valuable insights and predictions for the upcoming days.
Trend Analysis:
...Recent News & Updates
- 2024-04-15 08:47
- 2024-03-14 08:00
- 2024-03-13 20:00
- 2024-03-05 08:00
- 2024-03-04 19:00
- 2024-02-28 16:42
- 2024-02-28 16:01
- 2024-02-28 08:50
- 2024-02-28 03:01
- 2024-02-27 19:50
- 2024-02-21 09:55
- 2024-02-20 20:55
- 2024-02-12 08:50
- 2024-02-11 19:50
- 2024-01-31 09:55
- 2024-01-30 20:55
- 2024-01-29 08:00
- 2024-01-28 19:00
- 2024-01-25 05:43
- 2024-01-24 08:50
- 2024-01-23 19:50
- 2024-01-23 09:55
- 2024-01-22 20:55
- 2024-01-15 09:55
- 2024-01-14 20:55
- 2024-01-09 08:00
- 2024-01-08 19:00
- 2024-01-03 21:29
- 2024-01-03 16:05
- 2024-01-03 08:29
Page 1 of 5
previousnext